Deep Medicine | Avoiding the needle: how new imaging techniques are transforming prostate cancer detection

02/09/23 • 56 min

You can find out more about Professor Emberton and his work here: https://iris.ucl.ac.uk/iris/browse/profile?upi=MEMBE52

You can find out more about Professor Emberton and his work here: https://iris.ucl.ac.uk/iris/browse/profile?upi=MEMBE52

Previous Episode

Deep Medicine | Different origins of cognitive impairment: implications for behavioural and pharmacologic intervention

You can find out more about Professor Leff and his work here: https://www.ucl.ac.uk/icn/people/alex-leff

Next Episode

Alzheimer’s of the heart

Welcome to this episode of Deep Medicine, with your Host Alexander Gray: the Chief Medical Officer of IDEA Pharma. Alex has been joined by Marie Schroeder, who is a Senior Associate at Novo Seeds (https://novoholdings.dk/novo-seeds/). When this episode was recorded, she was a Principal Scientist at Novo Nordisk in Copenhagen, specializing in heart failure. Marie has spent a significant component of her career examining the role of amyloid in the pathogenesis of cardiomyopathy and is now involved in development programmes for assets aimed at treating patients with hereditary and acquired cardiac amyloidosis, as well as other trials examining cytokine blockade for the management of cardio-renal disease. Alex had a chance to discuss the parallels – and differences – between CNS and cardiac amyloid disease, from both pathologic and therapeutic perspectives.

You can find out more about Dr Schroeder and her work here:

https://www.novonordisk.com/careers/career-areas/research-and-development/cvd-researchers.html